RecruitingNCT06546943
Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations (GeM-PEx)
Sponsor
University of Colorado, Denver
Enrollment
50 participants
Start Date
Feb 4, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).
Eligibility
Min Age: 6 YearsMax Age: 25 Years
Inclusion Criteria3
- years old
- Confirmed diagnosis of cystic fibrosis (based on sweat chloride and/or two known disease causing CF mutations)
- access to a smart phone and/or internet connection and the ability to complete remote telehealth visits
Exclusion Criteria3
- known type 1 or type 2 diabetes, monogenic diabetes
- critical illness requiring admission to the ICU
- pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06546943
Related Trials
Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
NCT074846076 locations
Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
NCT0694053118 locations
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
NCT0554828360 locations